Insider · CIK 0001509032

CAPITELLI SARA B

Reports to the SEC for 1 company · ROCKVILLE, MD

sec.gov

Transactions

Companies

Filings

CIK

0001509032

Forms 4 and 5

Insider transactions

16 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2018-07-12	CASI Pharmaceuticals, Inc (DE)M Exercise/Conversion	VP Fin & Principal Account Off	MExercise/Conversion	+35K sh	$1.99	+$69.5K	35,000
2018-07-12	CASI Pharmaceuticals, Inc (DE)F Tax Payment	VP Fin & Principal Account Off	FTax Payment	−8,400 sh	$7.49	−$62.9K	26,600
2018-07-12	CASI Pharmaceuticals, Inc (DE)D Disposition to Issuer	VP Fin & Principal Account Off	DDisposition to Issuer	−26.6K sh	$7.49	−$199K	0
2018-07-12	CASI Pharmaceuticals, Inc (DE)Employee Stock Option (Right to Buy)M Exercise/Conversion	VP Fin & Principal Account Off	MExercise/Conversion	−35K sh	—	—	0
2018-04-12	CASI Pharmaceuticals, Inc (DE)M Exercise/Conversion	VP Fin & Principal Account Off	MExercise/Conversion	+27K sh	$0.88	+$23.7K	26,978
2018-04-12	CASI Pharmaceuticals, Inc (DE)F Tax Payment	VP Fin & Principal Account Off	FTax Payment	−8,200 sh	$6.62	−$54.3K	18,778
2018-04-12	CASI Pharmaceuticals, Inc (DE)D Disposition to Issuer	VP Fin & Principal Account Off	DDisposition to Issuer	−18.8K sh	$6.62	−$124K	0
2018-04-12	CASI Pharmaceuticals, Inc (DE)Employee Stock Option (Right to Buy)M Exercise/Conversion	VP Fin & Principal Account Off	MExercise/Conversion	−27K sh	—	—	0
2017-09-29	CASI Pharmaceuticals, Inc (DE)Stock Options (Right to Buy)A Award	VP Fin & Principal Account Off	AAward	+20K sh	—	—	20,000
2017-06-08	CASI Pharmaceuticals, Inc (DE)Stock Options (Right to Buy)A Award	VP Fin & Principal Account Off	AAward	+50K sh	—	—	50,000
2016-03-02	CASI Pharmaceuticals, Inc (DE)Stock Options (Right to Buy)A Award	VP Fin & Principal Account Off	AAward	+35K sh	—	—	35,000
2015-04-06	CASI Pharmaceuticals, Inc (DE)Stock Options (Right to Buy)A Award	VP Fin & Principal Account Off	AAward	+65K sh	—	—	65,000
2013-05-30	CASI Pharmaceuticals, Inc (DE)Stock Options (Right to Buy)A Award	VP Fin & Principal Account Off	AAward	+125K sh	—	—	125,000
2012-08-15	CASI Pharmaceuticals, Inc (DE)Stock Options (Right to Buy)A Award	VP Fin & Principal Account Off	AAward	+20K sh	—	—	20,000
2012-08-15	CASI Pharmaceuticals, Inc (DE)Stock Options (Right to Buy)A Award	VP Fin & Principal Account Off	AAward	+35K sh	—	—	35,000
2011-01-10	CASI Pharmaceuticals, Inc (DE)Stock Options (Right to Buy)A Award	VP Fin & Principal Account Off	AAward	+10K sh	—	—	10,000

Recent filings

Accepted (ET)
Jul 134
CAPITELLI SARA B0001144204-18-038360
SEC(opens sec.gov)
Apr 134
CAPITELLI SARA B0001144204-18-020555
SEC(opens sec.gov)
Oct 34
CAPITELLI SARA B0001144204-17-051254
SEC(opens sec.gov)
Jun 94
CASI Pharmaceuticals, Inc.0001144204-17-031973
SEC(opens sec.gov)
Mar 44
CASI Pharmaceuticals, Inc.0001144204-16-086167
SEC(opens sec.gov)
Apr 84
CASI Pharmaceuticals, Inc.0001144204-15-021872
SEC(opens sec.gov)
Nov 144
CASI Pharmaceuticals, Inc.0001144204-14-068917
SEC(opens sec.gov)
May 314
CAPITELLI SARA B0001144204-13-032715
SEC(opens sec.gov)
Aug 174
CAPITELLI SARA B0001144204-12-046863
SEC(opens sec.gov)
Jan 124
CAPITELLI SARA B0001209191-11-002937
SEC(opens sec.gov)

Companies

CASI Pharmaceuticals, Inc (DE)VP Fin & Principal Account Off

Address

ENTREMED, INC. 9640 MEDICAL CENTER DRIVE

ROCKVILLE, MD, 20850